Although patients with atherosclerotic cardiovascular disease and high levels of low-density lipoprotein (LDL) cholesterol benefited from receiving evolocumab plus statin therapy, the results of the randomized FOURIER trial did not impress Wall Street as shares of the drug’s manufacturer, Amgen, declined shortly after the findings were announced.

Siemens Healthineers and medical technology company HeartFlow have collaborated on a comprehensive, noninvasive heart technology to help diagnose and manage patients who may have coronary artery disease (CAD).

Romeo Pavlic, MD, a cardiologist from Spokane, Washington, agreed to pay $300,000 to settle a lawsuit alleging he overbilled Medicare and Medicaid patients, the Spokesman-Review reports.

AliveCor has introduced Kardia Pro, a cloud-based software platform that allows physicians to monitor patients who use the corresponding mobile electrocardiogram, Kardia Mobile.

In 2011 and 2012, hospitals in the U.S. did not often comply with Medicare requirements on how to appropriately bill for right heart catheterizations performed during the same patient encounter as heart biopsies, according to a report from the HHS Office of Inspector General (OIG).

The Penn Cardiovascular Institute hired Daniel P. Kelly, MD, as its director to oversee a team of basic, translational and clinical researchers.

An analysis of randomized clinical trials found that the general population should not use omega-3 fish oil supplements to prevent heart disease, according to a science advisory from the American Heart Association (AHA).

In 2015, a suboptimal diet accounted for 222,100 cardiovascular disease deaths among men and 193,400 cardiovascular disease deaths among women in the U.S., according to an analysis of national data.